Home > Publications database > Loss of Elp1 in cerebellar granule cell progenitors models ataxia phenotype of Familial Dysautonomia. > print |
001 | 291648 | ||
005 | 20250814095443.0 | ||
024 | 7 | _ | |a 10.1016/j.nbd.2024.106600 |2 doi |
024 | 7 | _ | |a pmid:38996985 |2 pmid |
024 | 7 | _ | |a 0969-9961 |2 ISSN |
024 | 7 | _ | |a 1095-953X |2 ISSN |
024 | 7 | _ | |a altmetric:172558321 |2 altmetric |
037 | _ | _ | |a DKFZ-2024-01472 |
041 | _ | _ | |a English |
082 | _ | _ | |a 570 |
100 | 1 | _ | |a Arnskötter, Frederik |0 P:(DE-HGF)0 |b 0 |e First author |
245 | _ | _ | |a Loss of Elp1 in cerebellar granule cell progenitors models ataxia phenotype of Familial Dysautonomia. |
260 | _ | _ | |a [Amsterdam] |c 2024 |b Elsevier |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1721043694_17125 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a KFZ-ZMBH Alliance /#EA:B430#LA:B430# |
520 | _ | _ | |a Familial Dysautonomia (FD) is an autosomal recessive disorder caused by a splice site mutation in the gene ELP1, which disproportionally affects neurons. While classically characterized by deficits in sensory and autonomic neurons, neuronal defects in the central nervous system have also been described. Although ELP1 expression remains high in the normal developing and adult cerebellum, its role in cerebellar development is unknown. To explore the role of Elp1 in the cerebellum, we knocked out Elp1 in cerebellar granule cell progenitors (GCPs) and examined the outcome on animal behavior and cellular composition. We found that GCP-specific conditional knockout of Elp1 (Elp1cKO) resulted in ataxia by 8 weeks of age. Cellular characterization showed that the animals had smaller cerebella with fewer granule cells. This defect was already apparent as early as 7 days after birth, when Elp1cKO animals also had fewer mitotic GCPs and shorter Purkinje dendrites. Through molecular characterization, we found that loss of Elp1 was associated with an increase in apoptotic cell death and cell stress pathways in GCPs. Our study demonstrates the importance of ELP1 in the developing cerebellum, and suggests that loss of Elp1 in the GC lineage may also play a role in the progressive ataxia phenotypes of FD patients. |
536 | _ | _ | |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312) |0 G:(DE-HGF)POF4-312 |c POF4-312 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a Cerebellum |2 Other |
650 | _ | 7 | |a Development |2 Other |
650 | _ | 7 | |a ELP1 |2 Other |
650 | _ | 7 | |a Elongator complex |2 Other |
650 | _ | 7 | |a Familial Dysautonomia |2 Other |
650 | _ | 7 | |a Granule cell progenitor |2 Other |
650 | _ | 7 | |a Neurodevelopmental disorder |2 Other |
650 | _ | 7 | |a ataxia |2 Other |
700 | 1 | _ | |a da Silva, Patricia Benites Goncalves |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Schouw, Mackenna Elisa |0 P:(DE-He78)5594c679f326d172a700b0348505d0a0 |b 2 |
700 | 1 | _ | |a Lukasch, Chiara |0 P:(DE-He78)dd00524c9fcf576d8a3a04d23598f750 |b 3 |u dkfz |
700 | 1 | _ | |a Bianchini, Luca |0 P:(DE-He78)c46ef00deda8baa32d5bbefbea3bedb2 |b 4 |u dkfz |
700 | 1 | _ | |a Sieber, Laura |0 P:(DE-He78)a4101d4d75f0b7d1f24f67ccbe63164b |b 5 |u dkfz |
700 | 1 | _ | |a Garcia-Lopez, Jesus |b 6 |
700 | 1 | _ | |a Ahmad, Shiekh Tanveer |b 7 |
700 | 1 | _ | |a Li, Yiran |b 8 |
700 | 1 | _ | |a Lin, Hong |b 9 |
700 | 1 | _ | |a Joshi, Piyush |0 P:(DE-He78)ee036c22158d4b18f5228616af640355 |b 10 |u dkfz |
700 | 1 | _ | |a Spänig, Lisa |0 P:(DE-He78)32e1cd66202cf8dcee5c06d46ff9c92e |b 11 |u dkfz |
700 | 1 | _ | |a Rados, Magdalena |0 P:(DE-He78)6e20f186b61ef367bb80e3012e672a28 |b 12 |
700 | 1 | _ | |a Roiuk, Mykola |0 P:(DE-He78)4543601bf14234f35021d658a5228201 |b 13 |u dkfz |
700 | 1 | _ | |a Sepp, Mari |b 14 |
700 | 1 | _ | |a Zuckermann, Marc |0 P:(DE-He78)2a8fbc2efe7e5e468472d57f724fe39b |b 15 |u dkfz |
700 | 1 | _ | |a Northcott, Paul A |b 16 |
700 | 1 | _ | |a Patrizi, Annarita |0 P:(DE-He78)7de884e25564c58f26d5c8dbed578256 |b 17 |u dkfz |
700 | 1 | _ | |a Kutscher, Lena |0 P:(DE-He78)a56d7a8e916d458441b5ac9484d73c5d |b 18 |e Last author |u dkfz |
773 | _ | _ | |a 10.1016/j.nbd.2024.106600 |g Vol. 199, p. 106600 - |0 PERI:(DE-600)1471408-5 |p 106600 |t Neurobiology of disease |v 199 |y 2024 |x 0969-9961 |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/291648/files/1-s2.0-S0969996124002006-main.pdf |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/291648/files/1-s2.0-S0969996124002006-main.pdf?subformat=pdfa |x pdfa |
909 | C | O | |o oai:inrepo02.dkfz.de:291648 |p VDB |p OpenAPC |p openCost |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)5594c679f326d172a700b0348505d0a0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)dd00524c9fcf576d8a3a04d23598f750 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)c46ef00deda8baa32d5bbefbea3bedb2 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)a4101d4d75f0b7d1f24f67ccbe63164b |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)ee036c22158d4b18f5228616af640355 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)32e1cd66202cf8dcee5c06d46ff9c92e |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)6e20f186b61ef367bb80e3012e672a28 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)4543601bf14234f35021d658a5228201 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)2a8fbc2efe7e5e468472d57f724fe39b |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 P:(DE-He78)7de884e25564c58f26d5c8dbed578256 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)a56d7a8e916d458441b5ac9484d73c5d |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-312 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Funktionelle und strukturelle Genomforschung |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NEUROBIOL DIS : 2022 |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-04-12T14:49:08Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-04-12T14:49:08Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-04-12T14:49:08Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-08-23 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-08-23 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-08-23 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b NEUROBIOL DIS : 2022 |d 2023-08-23 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2023-08-23 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2023-08-23 |
915 | p | c | |a APC keys set |2 APC |0 PC:(DE-HGF)0000 |
915 | p | c | |a Local Funding |2 APC |0 PC:(DE-HGF)0001 |
915 | p | c | |a DFG OA Publikationskosten |2 APC |0 PC:(DE-HGF)0002 |
915 | p | c | |a DEAL: Elsevier 09/01/2023 |2 APC |0 PC:(DE-HGF)0125 |
915 | p | c | |a DOAJ Journal |2 APC |0 PC:(DE-HGF)0003 |
920 | 2 | _ | |0 I:(DE-He78)B430-20160331 |k B430 |l Entwicklungsbiolog. Ursprünge pädiatrischer Krebserkrankungen |x 0 |
920 | 1 | _ | |0 I:(DE-He78)B430-20160331 |k B430 |l Entwicklungsbiolog. Ursprünge pädiatrischer Krebserkrankungen |x 0 |
920 | 1 | _ | |0 I:(DE-He78)B140-20160331 |k B140 |l B140 Signal Transduction in Cancer |x 1 |
920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 2 |
920 | 1 | _ | |0 I:(DE-He78)A320-20160331 |k A320 |l A320 NWG Neuronal signaling and morphogenesis |x 3 |
920 | 0 | _ | |0 I:(DE-He78)B430-20160331 |k B430 |l Entwicklungsbiolog. Ursprünge pädiatrischer Krebserkrankungen |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)B430-20160331 |
980 | _ | _ | |a I:(DE-He78)B140-20160331 |
980 | _ | _ | |a I:(DE-He78)B062-20160331 |
980 | _ | _ | |a I:(DE-He78)A320-20160331 |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a APC |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|